​

Cara Therapeutics Ownership | Who Owns Cara Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Cara Therapeutics Ownership Summary

Cara Therapeutics is owned by 24.56% institutional investors, 15.74% insiders, and 59.70% retail investors. Vanguard group is the largest institutional shareholder, holding 4.12% of CARA shares. Disciplined Growth - Small Cap Growth is the top mutual fund, with 1.48% of its assets in Cara Therapeutics shares.

CARA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCara Therapeutics24.56%15.74%59.70%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group2.25M4.12%$580.59K
Disciplined growth investors inc /mn1.94M3.55%$499.42K
Chescapmanager1.70M3.12%$439.14K
Farallon capital management1.56M2.85%$401.51K
Bnp paribas arbitrage, snc1.08M1.97%$277.82K
Renaissance1.07M1.95%$274.96K
Two sigma advisers, lp861.60K1.58%$222.29K
Blackrock744.71K1.36%$192.13K
Millennium management586.75K1.07%$151.38K
Bank of america corp /de/477.68K0.88%$123.24K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Chescapmanager1.70M0.04%$439.14K
Disciplined growth investors inc /mn1.94M0.01%$499.42K
Adar1 capital management159.47K0.01%$41.14K
Farallon capital management1.56M0.00%$401.51K
Virtu financial75.99K0.00%$20.00K
Cypress capital management llc (wy)5.00K0.00%$1.29K
Corsair capital management19.86K0.00%$5.13K
Renaissance1.07M0.00%$274.96K
Two sigma advisers, lp861.60K0.00%$222.29K
B. riley wealth advisors61.61K0.00%$15.89K

Top Buyers

HolderShares% AssetsChange
Bnp paribas arbitrage, snc1.08M0.00%790.60K
Jane street group376.50K-376.50K
Goldman sachs group389.68K-338.04K
Two sigma advisers, lp861.60K0.00%201.70K
Adar1 capital management159.47K0.01%159.47K

Top Sellers

HolderShares% AssetsChange
Blackrock744.71K--2.68M
Rosalind advisors---1.55M
State street180.80K--822.15K
Geode capital management472.69K--548.91K
Acuitas investments---512.21K

New Positions

HolderShares% AssetsChangeValue
Adar1 capital management159.47K0.01%159.47K$41.14K
Virtu financial75.99K0.00%75.99K$20.00K
Qube research66.61K-66.61K$17.19K
Corsair capital management19.86K0.00%19.86K$5.13K
Macquarie group2.38K-2.38K$614.00

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-10.00
Corecap advisors-17.00
Sound income strategies-100.00
Abich financial wealth management-140.00
Truvestments capital-176.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202466-17.50%13,467,508-23.85%242.34%12-61.29%2931.82%
Jun 30, 202480-20.00%17,686,050-25.10%321.70%31-13.89%22-33.33%
Mar 31, 2024100-11.50%23,611,820-2.99%432.17%36-21.74%33-2.94%
Dec 31, 2023113-10.32%24,339,169-10.27%441.78%46-11.54%34-19.05%
Sep 30, 2023126-10.00%27,124,312-7.71%501.69%52-24.64%427.69%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Disciplined Growth - Small Cap Growth811.50K1.48%811.50K
Fidelity Extended Market Index259.89K0.47%-1.71K
Disciplined Growth Small Cap Growth SP186.57K0.34%-
Vanguard Health Care ETF164.37K0.30%-408.00
NT R2000 Value Index Fund - NL125.06K0.23%-20.83K
NT R2000 Index Fund - NL121.34K0.22%-2.41K
Vanguard Total Stock Mkt Idx Inv112.86K0.21%5.00
NT R2000 Index Fund - DC - NL - 296.02K0.18%-2.26K
NT R2000 Value Index Fund - L95.20K0.17%2.40K
Northern Trust Russell 2000 Value Index95.20K0.17%2.40K

Recent Insider Transactions

DateNameRoleActivityValue
Nov 04, 2024Posner Christopher PRESIDENT AND CEOSell$1.06K
Aug 01, 2024Posner Christopher PRESIDENT AND CEOSell$1.45K
May 02, 2024Posner Christopher PRESIDENT AND CEOSell$2.95K
Apr 05, 2024Goncalves Joana CHIEF MEDICAL OFFICERSell$2.28K
Apr 05, 2024Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C.Sell$2.28K

Insider Transactions Trends

DateBuySell
2024 Q4-1
2024 Q3-1
2024 Q2-3
2024 Q1-5
2023 Q4-1

CARA Ownership FAQ

Who Owns Cara Therapeutics?

Cara Therapeutics shareholders are primarily institutional investors at 24.56%, followed by 15.74% insiders and 59.70% retail investors. The average institutional ownership in Cara Therapeutics's industry, Biotech Stocks , is 109.70%, which Cara Therapeutics falls below.

Who owns the most shares of Cara Therapeutics?

Cara Therapeutics’s largest shareholders are Vanguard group (2.25M shares, 4.12%), Disciplined growth investors inc /mn (1.94M shares, 3.55%), and Chescapmanager (1.7M shares, 3.12%). Together, they hold 10.79% of Cara Therapeutics’s total shares outstanding.

Does Blackrock own Cara Therapeutics?

Yes, BlackRock owns 1.36% of Cara Therapeutics, totaling 744.71K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 192.13K$. In the last quarter, BlackRock decreased its holdings by -2.677M shares, a -78.23% change.

Who is Cara Therapeutics’s biggest shareholder by percentage of total assets invested?

Chescapmanager is Cara Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.04% of its assets in 1.7M Cara Therapeutics shares, valued at 439.14K$.

Who is the top mutual fund holder of Cara Therapeutics shares?

Disciplined Growth - Small Cap Growth is the top mutual fund holder of Cara Therapeutics shares, with 1.48% of its total shares outstanding invested in 811.5K Cara Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools